Skip Navigation
National Cancer Institute
U.S. National Institutes of Health

Advancing the national research effort to transform cancer care through biomarker, imaging, and quality of life studies: 2012 Funding Program Announcement Now Available


Funded Cooperative Groups (CGs) and funded Community Clinical Oncology Program (CCOP) Research Bases are invited to apply for funding to support biomarker, imaging, and quality of life studies with or without Cost-Effectiveness Analysis (CEA) proposals which are associated with NCI clinical trial concepts.

Integral and/or integrated studies associated with Phase 3 treatment trials and cancer prevention trials are eligible. Only randomized Phase 3 clinical trials are eligible for CEA proposals. Support of Phase 2 clinical trials is limited to large (≥ 100 patients), randomized treatment trials with an integral and/or integrated biomarker or imaging study(ies).

This is an "open competition" announcement with no specific receipt date.

New 2012 Funding: Biomaker, Imaging and Quality of Life Studies Funding Program (BIQSFP). Download Complete 2012 Announcement (PDF File, 125KB)